Moderna, Inc. (MRNA) has recently updated its financial outlook, announcing an adjustment of its expected cash and cash equivalents at the end of 2026 to a range of $4.5 billion to $5.0 billion.

BUZZ - Marriott stock rises as it raises its annual growth outlook and reports better-than-expected third-quarter results

Equities: AI themes support selective overweight – HSBC

Travel demand remains strong! Marriott Hotels (MAR.US) Q3 profit and RevPAR exceed expectations, raising full-year outlook

Lumentum reported adjusted earnings per share of $4.57 for the first fiscal quarter, exceeding the market estimate of $4.21; it expects net revenue for the second fiscal quarter to be between $1.58 billion and $1.63 billion, higher than the market estimate of $1.48 billion.